Open access
Jul 2026
Circulating NSUN6 serves as a prognostic biomarker for early metastasis in HCC via hippo pathway modulation.
The findings establish the NSUN6-SAV1-YAP axis as a key epitranscriptomic tumor-suppressive mechanism and support circulating NSUN6 as a potential biomarker for early risk stratification in HCC.
Xutong Li, Honghai Xu, Yu Chang et al.
· Journal of experimental & cl... · 0 citations